Moleculin Biotech Stock Is Sinking Friday: What's Going On? - Moleculin Biotech (NASDAQ:MBRX)

Moleculin Biotech updates MIRACLE trial for AML and prices a $9.3M offering at $0.75, driving MBRX shares down 63%. Read full data.

Raccontata dabenzinga.com